The research of the ticagrelor and the clopidogrel in improving the slow flow / no- reflow in the interventional surgery of acute coronary syndrome (ACS) patients and the impact of cardiovascular and cerebrovascular events in post-operative

Trial Profile

The research of the ticagrelor and the clopidogrel in improving the slow flow / no- reflow in the interventional surgery of acute coronary syndrome (ACS) patients and the impact of cardiovascular and cerebrovascular events in post-operative

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2016 Status changed from recruiting to completed.
    • 08 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top